Results 141 to 150 of about 3,401,628 (310)

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

A venir: l'école thématique MAPS 13

open access: yes, 2019
MAPS 13, même pas peur! Une nouvelle école thématique du réseau MAPS financée par le CNRS se tiendra du 21 au 26 Juin 2020 en Normandie. Du 21 au 26 qu'on se le dise! pas avant, pas après!
Réseau MAPS
core  

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Participants MAPS 10

open access: yes, 2017
La liste des participants prévus pour MAPS 10 est disponible Parmi plus de 50 demandes, les heureux candidats sélectionnés sont: Ansobi Onsimbie Papy Université de Kinshasa Kinshasa Barge Olivier CNRS Berrias-et-Casteljau Baudrit Cedric INRA ...
Réseau MAPS
core  

Translating whole‐genome doubling into precision medicine in cancer

open access: yesMolecular Oncology, EarlyView.
Whole‐genome doubling creates a WGD‐positive tumor state characterized by persistent chromosomal instability, karyotypic diversification, and cellular stress. These same biological pressures drive aggressive tumor evolution while exposing therapeutic vulnerabilities, providing a rationale for WGD‐informed precision medicine. Whole‐genome doubling (WGD)
Sejung Lee, Junghyeok Lim, Jinhyuk Bhin
wiley   +1 more source

Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology

open access: yesMolecular Oncology, EarlyView.
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley   +1 more source

On αrω-Homeomorphisms in Topological Spaces

open access: yesJournal of New Theory, 2018
Abijection f:(X, τ)→(Y, σ) is calledαrω-homeomorphism if f and f−1 areαrω-continuous. Also we introduce new class of maps, namely αrωc-homeomorphismswhich form a subclass of αrω-homeomorphisms. This class of maps is closed undercomposition of maps.
Prabhavati S. Prabhavati S. Mandalageri   +1 more
doaj  

Modalités de participation MAPS 13

open access: yes, 2020
Modalités de participation La participation à MAPS 13 est soumise à sélection : les dossiers de candidature seront étudiés par le comité scientifique. Les tarifs sont fixés en fonction des statuts (voir ci-dessous).
Réseau MAPS
core  

Home - About - Disclaimer - Privacy